As of January 22, 2025, Haw Par (H02.SI) has a market cap of $1.86 billion USD. According to our data, Haw Par is ranked No.4240 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $1.86 B |
1.88%
|
Dec 31, 2024 | $1.82 B |
19.05%
|
Dec 29, 2023 | $1.53 B |
5.56%
|
Dec 30, 2022 | $1.45 B |
-13.34%
|
Dec 31, 2021 | $1.67 B |
8.61%
|
Dec 31, 2020 | $1.54 B |
-12.86%
|
Dec 31, 2019 | $1.77 B |
8.68%
|
Dec 31, 2018 | $1.63 B |
7.86%
|
Dec 29, 2017 | $1.51 B |
27.24%
|
Dec 30, 2016 | $1.19 B |
13.09%
|
Dec 31, 2015 | $1.05 B |
-0.74%
|
Dec 31, 2014 | $1.06 B |
7.79%
|
Dec 31, 2013 | $0.98 B |
35.77%
|
Dec 31, 2012 | $0.72 B |
31.83%
|
Dec 30, 2011 | $0.55 B |
-11.13%
|
Dec 31, 2010 | $0.62 B |
9.12%
|
Dec 30, 2009 | $0.56 B |
67.10%
|
Dec 31, 2008 | $0.34 B |
-47.47%
|
Dec 31, 2007 | $0.64 B |
2.69%
|
Dec 29, 2006 | $0.63 B |
42.10%
|
Dec 30, 2005 | $0.44 B |
3.34%
|
Dec 31, 2004 | $0.43 B |
19.71%
|
Dec 31, 2003 | $0.36 B |
42.20%
|
Dec 31, 2002 | $0.25 B |
-16.85%
|
Dec 31, 2001 | $0.30 B |
16.59%
|
Dec 29, 2000 | $0.26 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
GlaxoSmithKline
GSK
|
$68.38 B |
0.002 M
|
UK
|
Johnson & Johnson
JNJ
|
$347.78 B |
-0.005 M
|
USA
|
Pfizer
PFE
|
$148.34 B |
-0.006 M
|
USA
|
Sanofi
SNY
|
$128.55 B |
0.003 M
|
France
|
Novartis
NVS
|
$197.43 B |
0.007 M
|
Switzerland
|
Merck
MRK
|
$242.59 B |
0.007 M
|
USA
|
AbbVie
ABBV
|
$300.53 B |
0.002 M
|
USA
|
Eli Lilly
LLY
|
$676.92 B |
0.020 M
|
USA
|
AstraZeneca
AZN
|
$211.43 B |
0.005 M
|
UK
|
Bristol-Myers Squibb
BMY
|
$115.86 B |
0.003 M
|
USA
|
Takeda Pharmaceutical
TAK
|
$41.01 B |
-0.002 M
|
Japan
|
Amgen
AMGN
|
$147.53 B |
0.002 M
|
USA
|
Market Cap | = | H02.SI Stock Price | * | H02.SI Shares Outstanding |
= | $8.39 | * | 0.22 B | |
= | $1.86 B |